12 Biggest Mid-Day Losers For Monday

  • Microbot Medical Inc MBOT shares dropped 28.9 percent to $2.71. Microbot Medical reported a $10 million registered direct offering
  • ChinaCache International Holdings Ltd CCIH shares dipped 17.6 percent to $1.39.
  • NewLink Genetics Corp NLNK fell 12 percent to $11.03 in pre-market trading after the company reported that indoximod + PROVENGE resulted in statistically significant improvement in rPFS for patients with mCRPC in Phase 2 trial.
  • Juno Therapeutics Inc JUNO shares tumbled 8.6 percent to $23.95. Juno Therapeutics presented updated data from the TRANSCEND trial of JCAR017 at the ASCO Annual Meeting.
  • Spi Energy Co Ltd (ADR) SPI shares fell 8 percent to $1.39.
  • Endocyte, Inc. ECYT shares declined 7.3 percent to $1.77. Cowen & Co. downgraded Endocyte from Outperform to Market Perform, while Wedbush downgraded the stock from Outperform to Neutral.
  • Herbalife Ltd. HLF shares slipped 6.3 percent to $69.24 after the company cut its sales forecast for the current quarter. Herbalife expects Q2 revenue to decline by 6 percent to 2 percent, and adjusted earnings of $0.95 to $1.15 per share.
  • Insys Therapeutics Inc INSY shares dropped 6.1 percent to $13.23 as the company issued a statement on negative media reports.
  • Perrigo Company plc PRGO declined 5.7 percent to $69.29. RBC Capital downgraded Perrigo from Sector Perform to Underperform.
  • JinkoSolar Holding Co., Ltd. JKS shares dropped 3.5 percent to $18.12 after the company reported weaker-than-expected earnings for its first quarter.
  • CGG SA (ADR) CGG shares fell 3.2 percent to $6.61 after climbing 25.78 percent on Friday.
  • Keane Group Inc FRAC declined 3 percent to $15.12. Susquehanna initiated coverage on Keane Group with a Neutral rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!